Brainomix vs Infervision

Brainomix's stroke record covers e-ASPECTS (K221564, February 2023, product code POK), e-CTA, e-CTP and e-MRI, plus triage for ICH, LVO and stroke. In a 2024 real-world evaluation of e-Stroke, 1,130 scans (97.2%) were processed in about four minutes. Infervision's stroke record is InferRead CT Stroke.AI (K211179, August 2021), product code QAS, triage and notification on head CT, which its product page describes as hemorrhage triage. Brainomix's record covers ASPECTS and perfusion output, while Infervision's stroke record is triage and notification, so a stroke program that wants ASPECTS and perfusion output has its answer in Brainomix.

Infervision is the pick for a lung nodule screening program, with InferRead Lung CT.AI (K192880, July 2020, and K240554, May 2025) cleared as CT computer-aided detection. Brainomix's e-Lung quantifies fibrosis-type disease on CT, which an interstitial lung disease clinic would use. A chest X-ray TB screening program would look at InferRead DR Chest, evaluated in Lusaka, Zambia in 2025 at sensitivity 90.3% and specificity 39.2% at cut-off 0.12. InferRead DR Chest is not among Infervision's six openFDA decisions.